4.7 Article

Forecasting Individual Patient Response to Radiation Therapy in Head and Neck Cancer With a Dynamic Carrying Capacity Model

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ijrobp.2021.05.132

关键词

-

资金

  1. National Institutes of Health (NIH) from the National Cancer Institute (NCI) [U01CA244100]
  2. NIH from the National Institute for Dental and Craniofacial Research Academic Industrial Partnership [R01DE028290]
  3. NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program [1R01CA218148]
  4. NIH/NCI Cancer Center Support Grant (CCSG) Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program [P30CA016672]
  5. NIH/NCI Head and Neck Specialized Programs of Research Excellence Developmental Research Program Award [P50 CA097007]
  6. multidisciplinary Stiefel Oropharyngeal Research Fund of the University of Texas MD Anderson Cancer Center Charles and Daneen Stiefel Center for Head and Neck Cancer
  7. Cancer Center Support Grant [P30CA016672]

向作者/读者索取更多资源

The study successfully modeled and predicted individual patient responses to radiation therapy by combining mathematical modeling with weekly tumor volume data, achieving high accuracy in outcome predictions.
Purpose: To model and predict individual patient responses to radiation therapy. Methods and Materials: We modeled tumor dynamics as logistic growth and the effect of radiation as a reduction in the tumor carrying capacity, motivated by the effect of radiation on the tumor microenvironment. The model was assessed on weekly tumor volume data collected for 2 independent cohorts of patients with head and neck cancer from the H. Lee Moffitt Cancer Center (MCC) and the MD Anderson Cancer Center (MDACC) who received 66 to 70 Gy in standard daily fractions or with accelerated fractionation. To predict response to radiation therapy for individual patients, we developed a new forecasting framework that combined the learned tumor growth rate and carrying capacity reduction fraction (8) distribution with weekly measurements of tumor volume reduction for a given test patient to estimate 8, which was used to predict patient -specific outcomes. Results: The model fit data from MCC with high accuracy with patient-specific 8 and a fixed tumor growth rate across all patients. The model fit data from an independent cohort from MDACC with comparable accuracy using the tumor growth rate learned from the MCC cohort, showing transferability of the growth rate. The forecasting framework predicted patient specific outcomes with 76% sensitivity and 83% specificity for locoregional control and 68% sensitivity and 85% specificity for disease-free survival with the inclusion of 4 on-treatment tumor volume measurements. Conclusions: These results demonstrate that our simple mathematical model can describe a variety of tumor volume dynamics. Furthermore, combining historically observed patient responses with a few patient-specific tumor volume measurements allowed for the accurate prediction of patient outcomes, which may inform treatment adaptation and personalization. (c) 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据